150 related articles for article (PubMed ID: 8482278)
1. Cytokines predict coronary aneurysm formation in Kawasaki disease patients.
Lin CY; Lin CC; Hwang B; Chiang BN
Eur J Pediatr; 1993 Apr; 152(4):309-12. PubMed ID: 8482278
[TBL] [Abstract][Full Text] [Related]
2. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
[TBL] [Abstract][Full Text] [Related]
3. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease.
Lin CY; Lin CC; Hwang B; Chiang B
J Pediatr; 1992 Dec; 121(6):924-6. PubMed ID: 1447658
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
Evereklioglu C; Er H; Türköz Y; Cekmen M
Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
[TBL] [Abstract][Full Text] [Related]
5. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
[TBL] [Abstract][Full Text] [Related]
6. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes.
Mangge H; Kenzian H; Gallistl S; Neuwirth G; Liebmann P; Kaulfersch W; Beaufort F; Muntean W; Schauenstein K
Arthritis Rheum; 1995 Feb; 38(2):211-20. PubMed ID: 7848311
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions.
Matsubara T; Furukawa S; Yabuta K
Clin Immunol Immunopathol; 1990 Jul; 56(1):29-36. PubMed ID: 2113446
[TBL] [Abstract][Full Text] [Related]
8. Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis.
Bal A; Unlu E; Bahar G; Aydog E; Eksioglu E; Yorgancioglu R
Clin Rheumatol; 2007 Feb; 26(2):211-5. PubMed ID: 16583185
[TBL] [Abstract][Full Text] [Related]
9. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.
Gupta M; Noel GJ; Schaefer M; Friedman D; Bussel J; Johann-Liang R
J Clin Immunol; 2001 May; 21(3):193-9. PubMed ID: 11403226
[TBL] [Abstract][Full Text] [Related]
10. The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease.
Lin CY; Lin CC; Hwang B; Chiang BN
Eur J Pediatr; 1991 Jan; 150(3):179-82. PubMed ID: 1904353
[TBL] [Abstract][Full Text] [Related]
11. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression.
Liu Y; Ho RC; Mak A
J Affect Disord; 2012 Aug; 139(3):230-9. PubMed ID: 21872339
[TBL] [Abstract][Full Text] [Related]
12. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
[TBL] [Abstract][Full Text] [Related]
13. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
Filella X; Blade J; Guillermo AL; Molina R; Rozman C; Ballesta AM
Cancer Detect Prev; 1996; 20(1):52-6. PubMed ID: 8907203
[TBL] [Abstract][Full Text] [Related]
14. Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.
Si F; Wu Y; Gao F; Feng S; Liu R; Yi Q
Clin Exp Med; 2017 Nov; 17(4):451-457. PubMed ID: 28108813
[TBL] [Abstract][Full Text] [Related]
15. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.
Peter JB; Boctor FN; Tourtellotte WW
Neurology; 1991 Jan; 41(1):121-3. PubMed ID: 1985276
[TBL] [Abstract][Full Text] [Related]
16. Serum and urinary interleukin-6 (IL-6) levels as predicting factors of Kawasaki disease activity.
Chow YM; Lin CY; Hwang B
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993; 34(2):77-83. PubMed ID: 8372675
[TBL] [Abstract][Full Text] [Related]
17. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.
Barrera P; Boerbooms AM; Janssen EM; Sauerwein RW; Gallati H; Mulder J; de Boo T; Demacker PN; van de Putte LB; van der Meer JW
Arthritis Rheum; 1993 Aug; 36(8):1070-9. PubMed ID: 8393676
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of cytokines and soluble cytokine receptors in various T-cell malignancies.
Raziuddin S; Sheikha A; Abu-Eshy S; al-Janadi M
Cancer; 1994 May; 73(9):2426-31. PubMed ID: 8168046
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients.
Scott-Algara D; Vuillier F; Marasescu M; de Saint Martin J; Dighiero G
AIDS Res Hum Retroviruses; 1991 Apr; 7(4):381-6. PubMed ID: 1676897
[TBL] [Abstract][Full Text] [Related]
20. Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis.
Kart L; Buyukoglan H; Tekin IO; Altin R; Senturk Z; Gulmez I; Demir R; Ozesmi M
Mediators Inflamm; 2003 Feb; 12(1):9-14. PubMed ID: 12745543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
